|Articles|November 21, 2016
TKL Research Agrees to Sell Clinical Trials Division
TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division to QuintilesIMS.
Advertisement
TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division (CTD) to QuintilesIMS. TKL Research will retain its Research Clinics Division and its CTD will become part of Novella Clinical, a subsidiary of QuintilesIMS.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5